A Phase 3, Randomized, Open-label, Study to Assess the Immunogenicity and Safety of IVX-A12 when Co-administered with a Licensed Influenza Vaccine
Date:
01/01/2025
Lead Investigators:
Summary
No summary available
Date:
Lead Investigators:
No summary available